265 related articles for article (PubMed ID: 30712488)
1. Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction.
Adamek KE; Ramadurai D; Gunzburger E; Plomondon ME; Ho PM; Raghavan S
J Am Heart Assoc; 2019 Feb; 8(3):e011448. PubMed ID: 30712488
[TBL] [Abstract][Full Text] [Related]
2. Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study.
Ortolani P; Di Bartolomeo S; Marino M; Vagnarelli F; Guastaroba P; Rapezzi C; De Palma R
Eur Heart J Cardiovasc Pharmacother; 2015 Oct; 1(4):254-9. PubMed ID: 27532449
[TBL] [Abstract][Full Text] [Related]
3. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
[TBL] [Abstract][Full Text] [Related]
4. The impact of in-hospital cardiac rehabilitation program on medication adherence and clinical outcomes in patients with acute myocardial infarction in the Lazio region of Italy.
Soldati S; Di Martino M; Rosa AC; Fusco D; Davoli M; Mureddu GF
BMC Cardiovasc Disord; 2021 Sep; 21(1):466. PubMed ID: 34565326
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
[TBL] [Abstract][Full Text] [Related]
6. Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction.
Arnold SV; Spertus JA; Masoudi FA; Daugherty SL; Maddox TM; Li Y; Dodson JA; Chan PS
J Am Coll Cardiol; 2013 Nov; 62(19):1791-801. PubMed ID: 23973701
[TBL] [Abstract][Full Text] [Related]
7. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
[TBL] [Abstract][Full Text] [Related]
8. Does age modify the relationship between adherence to secondary prevention medications and mortality after acute myocardial infarction? A nested case-control study.
Lenzi J; Rucci P; Castaldini I; Protonotari A; Di Pasquale G; Di Martino M; Perrone E; Forti P; Fantini MP
Eur J Clin Pharmacol; 2015 Feb; 71(2):243-50. PubMed ID: 25529226
[TBL] [Abstract][Full Text] [Related]
9. Medication use in long-term survivors from the MONICA/KORA Myocardial Infarction Registry.
Amann U; Kirchberger I; Heier M; Thilo C; Kuch B; Meisinger C
Eur J Intern Med; 2018 Jan; 47():62-68. PubMed ID: 28826823
[TBL] [Abstract][Full Text] [Related]
10. Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.
Longenecker JC; Alfaddagh A; Zubaid M; Rashed W; Ridha M; Alenezi F; Alhamdan R; Akbar M; Bulbanat BY; Al-Suwaidi J
Int J Cardiol; 2013 Aug; 167(4):1406-11. PubMed ID: 22578736
[TBL] [Abstract][Full Text] [Related]
11. Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.
Fanaroff AC; Peterson ED; Kaltenbach LA; Cannon CP; Choudhry NK; Henry TD; Anstrom KJ; Cohen DJ; Fonseca E; Khan ND; Fonarow GC; Wang TY
JAMA Cardiol; 2020 Jan; 5(1):38-46. PubMed ID: 31721978
[TBL] [Abstract][Full Text] [Related]
12. Effect of adherence to evidence-based therapy after acute myocardial infarction on all-cause mortality.
Hamood H; Hamood R; Green MS; Almog R
Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1093-104. PubMed ID: 26183333
[TBL] [Abstract][Full Text] [Related]
13. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
[TBL] [Abstract][Full Text] [Related]
14. Long-term medication adherence after myocardial infarction: experience of a community.
Shah ND; Dunlay SM; Ting HH; Montori VM; Thomas RJ; Wagie AE; Roger VL
Am J Med; 2009 Oct; 122(10):961.e7-13. PubMed ID: 19560749
[TBL] [Abstract][Full Text] [Related]
15. Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population.
Huber CA; Meyer MR; Steffel J; Blozik E; Reich O; Rosemann T
Clin Ther; 2019 Jan; 41(1):107-117. PubMed ID: 30591287
[TBL] [Abstract][Full Text] [Related]
16. Cardiac medication prescribing and adherence after acute myocardial infarction in Chinese and South Asian Canadian patients.
Lai EJ; Grubisic M; Palepu A; Quan H; King KM; Khan NA
BMC Cardiovasc Disord; 2011 Sep; 11():56. PubMed ID: 21923931
[TBL] [Abstract][Full Text] [Related]
17. Association Between Preadmission Functional Status and Use and Effectiveness of Secondary Prevention Medications in Elderly Survivors of Acute Myocardial Infarction.
Chrischilles EA; Schneider KM; Schroeder MC; Letuchy E; Wallace RB; Robinson JG; Brooks JM
J Am Geriatr Soc; 2016 Mar; 64(3):526-35. PubMed ID: 26928940
[TBL] [Abstract][Full Text] [Related]
18. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes.
Choudhry NK; Glynn RJ; Avorn J; Lee JL; Brennan TA; Reisman L; Toscano M; Levin R; Matlin OS; Antman EM; Shrank WH
Am Heart J; 2014 Jan; 167(1):51-58.e5. PubMed ID: 24332142
[TBL] [Abstract][Full Text] [Related]
19. [Adherence to medication after myocardial infarction and its impact on outcome: a registry-based analysis from the Hungarian Myocardial Infarction Registry].
Jánosi A; Ofner P; Kiss Z; Kiss L; Kiss RG; Dinnyés J; Járai Z; Nagy G; Veress G; Ferenci T
Orv Hetil; 2017 Jul; 158(27):1051-1057. PubMed ID: 28670984
[TBL] [Abstract][Full Text] [Related]
20. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients.
Choudhry NK; Setoguchi S; Levin R; Winkelmayer WC; Shrank WH
Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1189-96. PubMed ID: 18956426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
